Author:
McDonald Andrew J.,Curt Katherine M.,Patel Ruchi P.,Kozlowski Hanna,Sackett Dan L.,Robey Robert W.,Gottesman Michael M.,Bates Susan E.
Reference53 articles.
1. Targeting histone deacetylases in T-cell lymphoma;Moskowitz;Leuk. Lymphoma,2016
2. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL);Duvic;Blood,2007
3. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma;Olsen;J. Clin. Oncol.,2007
4. Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma;Whittaker;J. Clin. Oncol.,2010
5. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma;Piekarz;J. Clin. Oncol.,2009
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献